ARCHIVES

NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors

This article is from The Cancer Letter archive.

Vol. 13 No. 38 | October 2, 1987

Download PDF Visit The Full Archive

Related Articles

Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say

December 19, 2014

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008

O’Leary Leads RPCI’s OR;

February 8, 2002

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

Letters To the Editor: NCI director Broder responds To Kopans On Mammography

October 8, 1993